Covered medications
Leap covers most medications
Search Leap's covered medications by medication name or condition. Your Care Guide can confirm what is available through your specific benefits.
A
| Drug name | Common conditions |
|---|---|
| Abilify Asimtufii | Schizophrenia and bipolar I disorder |
| Abilify Maintena | Schizophrenia and bipolar I disorder |
| Abrilada | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
| Actemra | Rheumatoid arthritis and related inflammatory conditions |
| Acthar Gel | H.P. Acthar | Infantile spasms, multiple sclerosis relapses, rheumatic and collagen disorders, other inflammatory conditions |
| Adakveo | Sickle cell disease |
| Adcetris | Hodgkin lymphoma and certain T-cell lymphomas |
| Advate | Hemophilia A |
| Adynovate | Hemophilia A |
| Afstyla | Hemophilia A |
| Ajovy | Migraine prevention |
| Aldurazyme | Mucopolysaccharidosis I (a rare metabolic disorder) |
| Alhemo | Hemophilia A or B |
| Alphanine Sd | Hemophilia B |
| Alprolix | Hemophilia B |
| Altuviiio | Hemophilia A |
| Alyglo | Primary immune deficiency |
| Alymsys | Colorectal, lung, kidney, cervical, ovarian cancers |
| Amjevita | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
| Amondys-45 | Duchenne muscular dystrophy |
| Amvuttra | Hereditary transthyretin amyloidosis |
| Aphexda | Stem cell collection for multiple myeloma |
| Apokyn | Parkinson's disease |
| Apretude | HIV prevention (PrEP) |
| Aralast Np | Alpha-1 antitrypsin deficiency |
| Aranesp | Anemia in chronic kidney disease and chemotherapy |
| Aristada | Schizophrenia |
| Aristada Initio | Schizophrenia |
| Arzerra | Chronic lymphocytic leukemia previously untreated or refractory |
| Asceniv | Primary immune deficiency |
| Aukelso | Osteoporosis and cancer-related bone loss |
| Aveed | Low testosterone |
| Avonex | Multiple sclerosis |
| Avsola | Rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, plaque psoriasis |
| Avtozma | Rheumatoid arthritis and related inflammatory conditions |
B
| Drug name | Common conditions |
|---|---|
| Bavencio | Merkel cell skin cancer and bladder cancer |
| Benefix | Hemophilia B |
| Benlysta | Lupus |
| Berinert | Hereditary angioedema |
| Betaseron | Multiple sclerosis |
| Bildyos | Osteoporosis and cancer-related bone loss |
| Bilprevda | Osteoporosis and cancer-related bone loss |
| Bivigam | Primary immune deficiency |
| Bkemv | Paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis |
| Bomyntra | Multiple solid tumors (immunotherapy) |
| Bortezomib | Multiple myeloma and mantle cell lymphoma |
| Bosaya | Osteoporosis and cancer-related bone loss |
| Briumvi | Multiple sclerosis |
| Brixadi | Opioid use disorder in adults |
C
| Drug name | Common conditions |
|---|---|
| Cabenuva | HIV |
| Cablivi | Acquired thrombotic thrombocytopenic purpura |
| Ceprotin | Protein C deficiency |
| Cerezyme | Type 1 Gaucher disease |
| Cimzia | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis |
| Cinqair | Severe asthma |
| Copaxone | Multiple sclerosis |
| Corifact | Factor XIII deficiency (a rare bleeding disorder) |
| Cosentyx | Plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis |
| Crysvita | X-linked hypophosphatemia |
| Cutaquig | Primary immune deficiency |
| Cuvitru | Primary immune deficiency |
| Cyltezo | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
| Cyramza | Gastric or gastroesophageal junction adenocarcinoma, metastatic colorectal cancer, non-small cell lung cancer, hepatocellular carcinoma |
D
| Drug name | Common conditions |
|---|---|
| Darzalex | Multiple myeloma |
| Darzalex Faspro | Multiple myeloma |
E
| Drug name | Common conditions |
|---|---|
| Edaravone | ALS (Lou Gehrig’s disease) |
| Elaprase | Hunter syndrome (a rare metabolic disorder) |
| Elelyso | Type 1 Gaucher disease |
| Elfabrio | Fabry disease |
| Eligard | Prostate cancer |
| Eloctate | Hemophilia A |
| Elrexfio | Multiple myeloma |
| Empliciti | Multiple myeloma |
| Enbrel | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis |
| Enhertu | HER2-positive breast, stomach, and lung cancer |
| Enoby | Osteoporosis and cancer-related bone loss |
| Entyvio | Ulcerative colitis and Crohn’s disease |
| Epkinly | Diffuse large B-cell lymphoma |
| Epoetin Alfa, 100 Units Esrd | Anemia in chronic kidney disease and chemotherapy |
| Epogen/Procrit | Anemia in chronic kidney disease and chemotherapy |
| Epysqli | Paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis |
| Erbitux | Colorectal cancer and head and neck cancer |
| Erelzi | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis |
| Erzofri | Schizophrenia and bipolar I disorder |
| Esperoct | Hemophilia A |
| Evenity | Osteoporosis |
| Evkeeza | Familial high cholesterol |
| Extavia | Multiple sclerosis |
F
| Drug name | Common conditions |
|---|---|
| Fabrazyme | Fabry disease |
| Fasenra | Severe asthma |
| Faslodex | Breast cancer |
| Feiba Nf | Hemophilia A or B with inhibitors |
| Feraheme | Iron deficiency anemia |
| Ferumoxytol | Feraheme | Iron deficiency anemia |
| Firazyr | Hereditary angioedema |
| Firmagon | Advanced prostate cancer |
| Flebogamma Dif | Primary immune deficiency |
| Fluphenazine Decanoate | Schizophrenia |
| Forteo | Osteoporosis |
| Fulphila | Lowers infection risk during chemotherapy |
| Fulvestrant | Breast cancer |
| Fuzeon | HIV |
| Fylnetra | Lowers infection risk during chemotherapy |
G
| Drug name | Common conditions |
|---|---|
| Gamifant | Hemophagocytic lymphohistiocytosis (primary and secondary) |
| Gammagard Liquid | Primary immune deficiency |
| Gammagard S-D | Primary immune deficiency |
| Gammaplex | Primary immune deficiency |
| Gamunex-C/Gammaked | Primary immune deficiency |
| Givlaari | Acute hepatic porphyria |
| Glassia | Alpha-1 antitrypsin deficiency |
| Granix | Lowers infection risk during chemotherapy |
H
| Drug name | Common conditions |
|---|---|
| Haegarda | Hereditary angioedema |
| Haldol Decanoate | Schizophrenia |
| Hemlibra | Hemophilia A |
| Hemofil M | Hemophilia A |
| Herceptin | HER2-positive breast and stomach cancer |
| Herceptin Hylecta | HER2-positive breast cancer |
| Hercessi | HER2-positive breast and stomach cancers |
| Herzuma | HER2-positive breast and stomach cancers |
| Hizentra | Primary immune deficiency |
| Hulio | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
| Humate-P | Von Willebrand disease and hemophilia A |
| Humira | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis |
| Hympavzi | Hemophilia A or B, with or without inhibitors |
| Hyqvia | Primary immune deficiency |
I
| Drug name | Common conditions |
|---|---|
| Ibandronate Sodium | Osteoporosis |
| Idacio | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
| Idelvion | Hemophilia B |
| Ilaris | Periodic fever syndromes and gout |
| Ilumya | Plaque psoriasis |
| Imfinzi | Lung cancer and other cancers (immunotherapy) |
| Imjudo | Liver and lung cancer (with other therapies) |
| Imuldosa | Ulcerative colitis and Crohn’s disease |
| Infed | Iron deficiency anemia |
| Inflectra | Rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, plaque psoriasis |
| Injectafer | Iron deficiency anemia |
| Invega Hafyera | Schizophrenia |
| Invega Trinza | Schizophrenia |
| Ixempra Kit | Advanced breast cancer |
| Ixinity | Hemophilia B |
J
| Drug name | Common conditions |
|---|---|
| Jemperli | Endometrial and other cancers (immunotherapy) |
| Jivi | Hemophilia A |
| Jobevne | Colorectal, lung, kidney, cervical, ovarian cancers |
| Jubbonti | Osteoporosis and bone loss |
| Jubereq | Osteoporosis and cancer-related bone loss |
K
| Drug name | Common conditions |
|---|---|
| Kadcyla | HER2-positive breast cancer |
| Kalbitor | Hereditary angioedema |
| Kanjinti | HER2-positive breast and stomach cancers |
| Kanuma | Lysosomal acid lipase deficiency |
| Keytruda | Many cancer types (immunotherapy) |
| Keytruda Qlex | Many cancer types (immunotherapy) |
| Kisunla | Alzheimer’s disease |
| Kovaltry | Hemophilia A |
| Krystexxa | Chronic gout |
L
| Drug name | Common conditions |
|---|---|
| Lamzede | Alpha-mannosidosis (a rare metabolic disorder) |
| Lanreotide | Acromegaly and neuroendocrine tumors |
| Lanreotide Acetate | Acromegaly and neuroendocrine tumors |
| Lemtrada | Multiple sclerosis |
| Leqembi | Alzheimer’s disease |
| Leqvio | High cholesterol |
| Leuprolide Acetate | Prostate cancer, endometriosis, early puberty |
| Libtayo | Skin and lung cancers (immunotherapy) |
| Loqtorzi | Nasopharyngeal and liver cancer (immunotherapy) |
| Lumizyme | Pompe disease |
| Lupron Depot-Ped | Early (precocious) puberty in children |
M
| Drug name | Common conditions |
|---|---|
| Mepsevii | Mucopolysaccharidosis VII (a rare metabolic disorder) |
| Mircera | Anemia in chronic kidney disease and chemotherapy |
| Monjuvi | Diffuse large B-cell lymphoma |
| Monoferric | Iron deficiency anemia |
| Mvasi | Colorectal, lung, kidney, cervical, ovarian cancers |
N
| Drug name | Common conditions |
|---|---|
| Naglazyme | Mucopolysaccharidosis VI (a rare metabolic disorder) |
| Neulasta | Lowers infection risk during chemotherapy |
| Neupogen | Lowers infection risk during chemotherapy |
| Nexviazyme | Pompe disease |
| Nivestym | Lowers infection risk during chemotherapy |
| Novoeight | Hemophilia A |
| Novoseven Rt | Hemophilia A or B with inhibitors |
| Nplate | Immune thrombocytopenia |
| Nucala | Severe asthma |
| Nulojix | Prevents organ rejection after kidney transplant |
| Nuwiq | Hemophilia A |
| Nypozi | Lowers infection risk during chemotherapy |
| Nyvepria | Lowers infection risk during chemotherapy |
O
| Drug name | Common conditions |
|---|---|
| Ocrevus | Multiple sclerosis |
| Ocrevus Zunovo | Multiple sclerosis |
| Octagam | Primary immune deficiency |
| Octreotide Acetate | Acromegaly and neuroendocrine tumors |
| Ogivri | HER2-positive breast and stomach cancers |
| Omlyclo | Moderate-to-severe allergic asthma and chronic hives |
| Omvoh | Ulcerative colitis and Crohn’s disease |
| Onpattro | Hereditary transthyretin amyloidosis |
| Ontruzant | HER2-positive breast and stomach cancers |
| Opdivo | Many cancer types (immunotherapy) |
| Opdivo Qvantig | Many cancer types (immunotherapy) |
| Opdualag | Melanoma (immunotherapy) |
| Orencia | Rheumatoid arthritis, psoriatic arthritis, and juvenile arthritis |
| Osenvelt | Osteoporosis and cancer-related bone loss |
| Osvyrti Pfs | Osteoporosis and cancer-related bone loss |
| Otulfi | Crohn’s disease, ulcerative colitis, plaque psoriasis, psoriatic arthritis |
| Oxlumo | Primary hyperoxaluria type 1 |
P
| Drug name | Common conditions |
|---|---|
| Padcev | Locally advanced or metastatic urothelial cancer |
| Pamidronate | High blood calcium and bone complications of cancer |
| Panhematin | Acute porphyria attacks |
| Panzyga | Primary immune deficiency |
| Pegasys | Chronic hepatitis B and hepatitis C |
| Perjeta | HER2-positive breast cancer |
| Perseris | Schizophrenia |
| Phesgo | HER2-positive breast cancer |
| Piasky | Paroxysmal nocturnal hemoglobinuria |
| Pombiliti | Pompe disease |
| Portrazza | Metastatic squamous non-small cell lung cancer with gemcitabine and cisplatin (first-line) |
| Poteligeo | Certain T-cell lymphomas (mycosis fungoides / Sézary syndrome) |
| Privigen | Primary immune deficiency |
| Prolia | Osteoporosis |
| Pyzchiva | Plaque psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis |
R
| Drug name | Common conditions |
|---|---|
| Rebif Rebidose | Multiple sclerosis |
| Rebinyn | Hemophilia B |
| Reblozyl | Anemia in beta-thalassemia and myelodysplastic syndromes |
| Reclast | Osteoporosis |
| Releuko | Lowers infection risk during chemotherapy |
| Remicade | Rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, pediatric ulcerative colitis and Crohn's |
| Renflexis | Rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriatic arthritis, plaque psoriasis |
| Retacrit | Anemia in chronic kidney disease and chemotherapy |
| Rezzayo | Serious fungal infections |
| Riabni | Non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis |
| Riastap | Acute bleeding episodes in congenital fibrinogen deficiency |
| Risperdal | Schizophrenia and bipolar disorder |
| Rituxan | Non-Hodgkin’s lymphoma, leukemia, and rheumatoid arthritis |
| Rixubis | Hemophilia B |
| Rolvedon | Lowers infection risk during chemotherapy |
| Ruconest | Hereditary angioedema |
| Ruxience | Non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis |
| Rybrevant | EGFR exon 20 insertion-mutant non-small cell lung cancer and EGFR-mutant non-small cell lung cancer with specific mutations |
| Rylaze | Acute lymphoblastic leukemia (part of chemo regimen) |
| Rystiggo | Myasthenia gravis |
| Rytelo | Anemia in myelodysplastic syndromes |
S
| Drug name | Common conditions |
|---|---|
| Saphnelo | Lupus |
| Sarclisa | Multiple myeloma |
| Selarsdi | Crohn’s disease, ulcerative colitis, plaque psoriasis, psoriatic arthritis |
| Sevenfact | Hemophilia A or B with inhibitors |
| Signifor Lar | Acromegaly and Cushing’s disease |
| Simlandi | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
| Simponi | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis |
| Skyrizi | Plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis |
| Soliris | Paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis |
| Spevigo | Generalized pustular psoriasis |
| Stelara | Plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis |
| Steqeyma | Plaque psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis |
| Stimufend | Lowers infection risk during chemotherapy |
| Sublocade | Opioid use disorder in adults |
| Sumatriptan Succinate / 6 Mg | Migraine attacks |
| Sunlenca | HIV |
| Sylvant | Castleman disease |
| Synagis | RSV prevention in high-risk infants |
T
| Drug name | Common conditions |
|---|---|
| Takhzyro | Hereditary angioedema |
| Talvey | Multiple myeloma |
| Tecentriq | Many cancer types (immunotherapy) |
| Tecentriq Hybreza | Many cancer types (immunotherapy) |
| Tecvayli | Multiple myeloma |
| Temsirolimus | Advanced kidney cancer |
| Tepezza | Thyroid eye disease |
| Tevimbra | Esophageal cancer (immunotherapy) |
| Tezspire | Severe asthma |
| Tivdak | Recurrent or metastatic cervical cancer after chemotherapy |
| Tofidence | Rheumatoid arthritis and related inflammatory conditions |
| Trazimera | HER2-positive breast and stomach cancers |
| Trelstar | Advanced prostate cancer |
| Tremfya | Plaque psoriasis and psoriatic arthritis |
| Tretten | Factor XIII deficiency (a rare bleeding disorder) |
| Triptodur | Early (precocious) puberty in children |
| Trodelvy | Unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, metastatic urothelial cancer |
| Truxima | Non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis |
| Tyenne | Rheumatoid arthritis and related inflammatory conditions |
| Tyruko | Multiple sclerosis and Crohn’s disease |
| Tysabri | Multiple sclerosis and Crohn’s disease |
| Tzield | Type 1 diabetes (delays onset) |
U
| Drug name | Common conditions |
|---|---|
| Udenyca | Lowers infection risk during chemotherapy |
| Ultomiris | Paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis |
| Uplizna | Neuromyelitis optica spectrum disorder |
| Uzedy | Schizophrenia |
V
| Drug name | Common conditions |
|---|---|
| Vectibix | Colorectal cancer |
| Vegzelma | Colorectal, lung, kidney, cervical, ovarian cancers |
| Venofer | Iron deficiency anemia |
| Veopoz | Paroxysmal nocturnal hemoglobinuria |
| Viltepso | Duchenne muscular dystrophy |
| Vimizim | Morquio A syndrome (a rare metabolic disorder) |
| Vivitrol | Treatment of alcohol dependence and prevention of relapse to opioid dependence |
| Vonvendi | Von Willebrand disease |
| Vpriv | Type 1 Gaucher disease |
| Vyepti | Migraine prevention |
| Vyondys-53 | Duchenne muscular dystrophy |
| Vyvgart | Myasthenia gravis |
| Vyvgart Hytrulo | Myasthenia gravis |
W
| Drug name | Common conditions |
|---|---|
| Wezlana | Plaque psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis |
| Wilate | Von Willebrand disease and hemophilia A |
X
| Drug name | Common conditions |
|---|---|
| Xembify | Primary immune deficiency |
| Xenpozyme | Acid sphingomyelinase deficiency |
| Xgeva | Bone complications from cancer that has spread to bone |
| Xolair | Severe allergic asthma and chronic hives |
| Xtrenbo | Osteoporosis and cancer-related bone loss |
| Xyntha | Hemophilia A |
Y
| Drug name | Common conditions |
|---|---|
| Yervoy | Melanoma and other cancers (immunotherapy) |
| Yesintek | Plaque psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis |
| Yeztugo | HIV prevention (PrEP) |
| Yuflyma | Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis |
Z
| Drug name | Common conditions |
|---|---|
| Zarxio | Lowers infection risk during chemotherapy |
| Ziextenzo | Lowers infection risk during chemotherapy |
| Zirabev | Colorectal, lung, kidney, cervical, ovarian cancers |
| Zoladex | Prostate cancer, breast cancer, endometriosis |
| Zymfentra | Crohn’s disease and ulcerative colitis |
| Zynlonta | Relapsed or refractory large B-cell lymphoma |
| Zynyz | Merkel cell skin cancer and anal cancer (immunotherapy) |
Ready to check coverage?
See if your medication is covered through your benefits.
Leap can confirm plan availability, coordinate prior authorization, and walk you through next steps.